Holding(s) in Company

RNS Number : 2188R
Spire Healthcare Group PLC
25 June 2015
 



 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1.   Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

 

2. Reason for the notification (please state Yes/No):

 

An acquisition or disposal of voting rights:                                YES

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

 

An event changing the breakdown of voting rights: (    )

 

Other (please specify):  Transfer of shares to 100% owned (in identical ratios) special purpose vehicle (Rozier Investments Limited Partnership)

 

3. Full name of person(s) subject to the notification obligation:

 

Cinven Limited
Cinven S.A

 

4. Full name of shareholder(s) (if different from 3.):

 

ROZIER INVESTMENTS LIMITED PARTNERSHIP

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):                                               22 June 2015

 

6. Date on which issuer notified:                       24 June 2015

    

 

7. Threshold(s) that is/are crossed or reached:         Following a disposal the holdings have reduced from 38.35% to 8.45%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY


ISIN: GB00BNLPYF73


ROZIER INVESTMENTS LIMITED PARTNERSHIP

153,813,661

153,813,661

33,890,326

33,890,326


8.45%


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument


Expiration Date




Exercise/Conversion Period/ Date



Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights




C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument


Exercise price

Expiration date




Exercise/Conversion period



Number of voting rights instrument refers to

% of voting rights









Nominal

Delta

 

Total (A+B+C)

Number of voting rights


% of voting rights


33,890,326

8.45%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Cinven Limited acts as manager of the following entities:

 

Fourth Cinven Fund (No.1) Limited Partnership (1.643%)

 

Fourth Cinven Fund (NO.2) Limited Partnership (1.714%)

 

Fourth Cinven Fund (NO.3-VCOC) Limited Partnership (1.699%)

 

Fourth Cinven Fund (NO.4) Limited Partnership (1.622%)

 

Fourth Cinven Fund (UBTI) Limited Partnership (0.913%)

 

Fourth Cinven (MACIF) Limited Partnership (0.024%),

 

together the "Cinven Funds".

The Cinven Funds and Fourth Cinven Fund Co-Investment Partnership (0.084%) are party to an agreement whereby Fourth Cinven Fund Co-Investment Partnership acts in accordance with the actions of the Cinven Funds, meaning that Cinven Limited also effectively controls Fourth Cinven Fund Co-Investment Partnership.

Cinven S.A. acts as manager of Fourth Cinven Fund FCPR (the "FCPR") (0.751%).

Cinven Funds and the FCPR are the beneficial owners of Rozier Investments Limited Partnership which is the registered holder of the shares as listed in section 8. The percentage figures in brackets show the ultimate beneficial ownership of each of the entities in the share capital of Spire Healthcare Group plc.

 

Proxy Voting:

 

10. Name of the proxy holder:                                                                N/A

     

                       

11. Number of voting rights proxy holder will cease to hold:        N/A

     

 

12. Date on which proxy holder will cease to hold voting rights: N/A

 

 

13. Additional information:                      See box 9 above

 

 

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc

 

15. Contact telephone number:

+ 44 (0)20 7427 9092

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVARRVRANUAR
UK 100

Latest directors dealings